Johnathon Elliot - Concepedia

Author

Johnathon Elliot

Also Known As

J. Elliot, J. W. ELLIOT, John Michael Elliot, Johnathon Elliot

Publications

247

Citations

H-Index

Concepts

All Affiliations

Johnathon Elliot is an author at University College London specializing in pathology, cancer research, and clinical trials.

#	Concept	H-Index	Publications	Citations
1	Health Sciences	1	1	57
2	Medicine	1	1	57
3	Immunology	1	1	57
4	Molecular Medicine	1	1	57
5	Pathology	1	1	57

Johnathon Elliot

Publications

238

Citations

H-Index

Page 1

	Year	Citations
Molecular MRD is strongly prognostic in patients with <i>NPM1</i>-mutated AML receiving venetoclax-based nonintensive therapy Jad Othman, Ing Soo Tiong, Jenny O’Nions, Blood Mrd NegativityMixed-phenotype Acute LeukemiaImmunologyPathologyMeasurable Residual Disease	2023	57
Erythropoietin mimics the acute phase response in critical illness Johnathon Elliot, Tanit Virankabutra, Stephen Jones, Critical Care	2003	55
Timing of high-dose methotrexate CNS prophylaxis in DLBCL: an analysis of toxicity and impact on R-CHOP delivery Matthew R. Wilson, Toby A. Eyre, Nicolás Martínez‐Calle, Blood Advances	2020	53
Real-world outcomes of newly diagnosed AML treated with venetoclax and azacitidine or low-dose cytarabine in the UK NHS Jad Othman, Ho Pui Jeff Lam, Sarah Leong, Blood Neoplasia	2024	26
Missed irradiation of cellular blood components for vulnerable patients: Insights from 10 years of <scp>SHOT</scp> data Johnathon Elliot, Shruthi Narayan, Debbi Poles, Transfusion	2020	19
Brexucabtagene autoleucel for relapsed or refractory mantle cell lymphoma in the United Kingdom: A real‐world intention‐to‐treat analysis Maeve O’Reilly, William Wilson, David Burns, HemaSphere	2024	17
Brexucabtagene Autoleucel for Relapsed/Refractory Mantle Cell Lymphoma: Real-World Outcomes in the United Kingdom Maeve O’Reilly, Robin Sanderson, William Wilson, Blood	2022	11

Page 1